Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA

Rebecca Earnest, Rockib Uddin, Nicholas Matluk, Nicholas Renzette, Katherine J. Siddle, Christine Loreth, Gordon Adams, Christopher H. Tomkins-Tinch, Mary E. Petrone, Jessica E. Rothman, Mallery I. Breban, Robert Tobias Koch, Kendall Billig, Joseph R. Fauver, Chantal B.F. Vogels, Sarah Turbett, Kaya Bilguvar, Bony De Kumar, Marie L. Landry, David R. Peaper, Kevin Kelly, Greg Omerza, Heather Grieser, Sim Meak, John Martha, Hannah H. Dewey, Susan Kales, Daniel Berenzy, Kristin Carpenter-Azevedo, Ewa King, Richard C. Huard, Sandra C. Smole, Catherine M. Brown, Timelia Fink, Andrew S. Lang, Glen R. Gallagher, Pardis C. Sabeti, Stacey Gabriel, Bronwyn L. MacInnis, New England Variant Investigation Team, Ryan Tewhey, Mark D. Adams, Daniel J. Park, Jacob E. Lemieux, Nathan D. Grubaugh
doi: https://doi.org/10.1101/2021.10.06.21264641
Rebecca Earnest
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rebecca.earnest@yale.edu nathan.grubaugh@yale.edu
Rockib Uddin
2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Matluk
3Maine Center for Disease Control and Prevention, Augusta, ME 04333
4Health and Environmental Testing Laboratory, Augusta, ME 04333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Renzette
5The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine J. Siddle
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Loreth
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Adams
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher H. Tomkins-Tinch
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary E. Petrone
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica E. Rothman
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mallery I. Breban
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Tobias Koch
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kendall Billig
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph R. Fauver
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal B.F. Vogels
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Turbett
2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaya Bilguvar
7Yale Center for Genome Analysis, Yale University, New Haven, CT 06510, USA
8Departments of Neurosurgery and Genetics, Yale School of Medicine, New Haven, CT 06510, USA
9Department of Medical Genetics, Acibadem University School of Medicine, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bony De Kumar
7Yale Center for Genome Analysis, Yale University, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie L. Landry
10Departments of Laboratory Medicine and Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Peaper
10Departments of Laboratory Medicine and Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Kelly
5The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg Omerza
5The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Grieser
3Maine Center for Disease Control and Prevention, Augusta, ME 04333
4Health and Environmental Testing Laboratory, Augusta, ME 04333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sim Meak
3Maine Center for Disease Control and Prevention, Augusta, ME 04333
4Health and Environmental Testing Laboratory, Augusta, ME 04333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Martha
3Maine Center for Disease Control and Prevention, Augusta, ME 04333
4Health and Environmental Testing Laboratory, Augusta, ME 04333
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah H. Dewey
11The Jackson Laboratory, Bar Harbor, ME 04609, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Kales
11The Jackson Laboratory, Bar Harbor, ME 04609, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Berenzy
11The Jackson Laboratory, Bar Harbor, ME 04609, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Carpenter-Azevedo
12Rhode Island Department of Health, State Health Laboratories, Providence, RI 02904, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewa King
12Rhode Island Department of Health, State Health Laboratories, Providence, RI 02904, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard C. Huard
12Rhode Island Department of Health, State Health Laboratories, Providence, RI 02904, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra C. Smole
13Massachusetts Department of Public Health, Boston MA 02130, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine M. Brown
13Massachusetts Department of Public Health, Boston MA 02130, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timelia Fink
13Massachusetts Department of Public Health, Boston MA 02130, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew S. Lang
13Massachusetts Department of Public Health, Boston MA 02130, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glen R. Gallagher
13Massachusetts Department of Public Health, Boston MA 02130, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pardis C. Sabeti
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Gabriel
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bronwyn L. MacInnis
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Tewhey
9Department of Medical Genetics, Acibadem University School of Medicine, Istanbul, Turkey
14Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111, USA
15Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME 04469, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark D. Adams
5The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Park
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob E. Lemieux
2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
6Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan D. Grubaugh
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
16Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06510, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rebecca.earnest@yale.edu nathan.grubaugh@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant quickly rose to dominance in mid-2021, displacing other variants, including Alpha. Studies using data from the United Kingdom and India estimated that Delta was 40-80% more transmissible than Alpha, allowing Delta to become the globally dominant variant. However, it was unclear if the ostensible difference in relative transmissibility was due mostly to innate properties of Delta’s infectiousness or differences in the study populations. To investigate, we formed a partnership with SARS-CoV-2 genomic surveillance programs from all six New England US states. By comparing logistic growth rates, we found that Delta emerged 37-163% faster than Alpha in early 2021 (37% Massachusetts, 75% New Hampshire, 95% Maine, 98% Rhode Island, 151% Connecticut, and 163% Vermont). We next computed variant-specific effective reproductive numbers and estimated that Delta was 58-120% more transmissible than Alpha across New England (58% New Hampshire, 68% Massachusetts, 76% Connecticut, 85% Rhode Island, 98% Maine, and 120% Vermont). Finally, using RT-PCR data, we estimated that Delta infections generate on average ∼6 times more viral RNA copies per mL than Alpha infections. Overall, our evidence indicates that Delta’s enhanced transmissibility could be attributed to its innate ability to increase infectiousness, but its epidemiological dynamics may vary depending on the underlying immunity and behavior of distinct populations.

Competing Interest Statement

NDG is a paid consultant for Tempus Labs for work unrelated to this manuscript and has received speaking fees from Goldman Sachs.

Funding Statement

This work was funded by CTSA Grant Number TL1 TR001864 (R.E. and M.E.P.), Fast Grant from Emergent Ventures at the Mercatus Center at George Mason University (N.D.G.), the Centers for Disease Control and Prevention (CDC) Broad Agency Announcement # 75D30120C09570 (N.D.G.) and # 75D30120C09605 (B.L.M), and CDC Baseline Surveillance Contract # 75D30121C10501 (Clinical Research Sequencing Platform, LLC).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Yale University (Connecticut) The Institutional Review Board from the Yale University Human Research Protection Program determined that the RT-qPCR testing and sequencing of de-identified remnant COVID-19 clinical samples obtained from clinical partners conducted in this study is not research involving human subjects (IRB Protocol ID: 2000028599). Jackson Laboratory (Connecticut) The Institutional Review Board of The Jackson Laboratory determined that use of de-identified residual COVID-19 clinical samples obtained from the Clinical Genomics Laboratory for RT-qPCR testing and sequencing for this study is not research involving human subjects (IRB Determination: 2020-NHSR-021). Mass General Brigham (Massachusetts) The Institutional Review Board of Partners Human Research determined that the use of excess, de-identified COVID-19 clinical specimens obtained within the Partners Healthcare network for RT-qPCR testing and genomic sequencing for this study is not research involving human subjects (IRB Protocol ID: 2019P003305). In addition, the Institutional Review Board of the Massachusetts Department of Public Health has reviewed and approved this study to perform genomic sequencing of coronaviruses (IRB Protocol ID: 1603078). Health and Environmental Testing Laboratory (Maine) A Memorandum of Understanding between The State of Maine Department of Health and Human Services and The Jackson Laboratory determined that extracted viral RNA from human respiratory specimens which have tested positive for SARS-CoV-2 and are used for sequencing will not be used in human subjects, in clinical trials, or for diagnostic purposes involving human subjects.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵# Co-senior author

Data Availability

A summary of the SARS-CoV-2 lineages used from GISAID are available in Tables S1-S3 and a complete list of GISAID acknowledgements are available in Data S1-S7. All other publicly available data and code used for this paper are available on github (https://github.com/grubaughlab/2021_paper_Delta-v-Alpha).

https://github.com/grubaughlab/2021_paper_Delta-v-Alpha

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Rebecca Earnest, Rockib Uddin, Nicholas Matluk, Nicholas Renzette, Katherine J. Siddle, Christine Loreth, Gordon Adams, Christopher H. Tomkins-Tinch, Mary E. Petrone, Jessica E. Rothman, Mallery I. Breban, Robert Tobias Koch, Kendall Billig, Joseph R. Fauver, Chantal B.F. Vogels, Sarah Turbett, Kaya Bilguvar, Bony De Kumar, Marie L. Landry, David R. Peaper, Kevin Kelly, Greg Omerza, Heather Grieser, Sim Meak, John Martha, Hannah H. Dewey, Susan Kales, Daniel Berenzy, Kristin Carpenter-Azevedo, Ewa King, Richard C. Huard, Sandra C. Smole, Catherine M. Brown, Timelia Fink, Andrew S. Lang, Glen R. Gallagher, Pardis C. Sabeti, Stacey Gabriel, Bronwyn L. MacInnis, New England Variant Investigation Team, Ryan Tewhey, Mark D. Adams, Daniel J. Park, Jacob E. Lemieux, Nathan D. Grubaugh
medRxiv 2021.10.06.21264641; doi: https://doi.org/10.1101/2021.10.06.21264641
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Rebecca Earnest, Rockib Uddin, Nicholas Matluk, Nicholas Renzette, Katherine J. Siddle, Christine Loreth, Gordon Adams, Christopher H. Tomkins-Tinch, Mary E. Petrone, Jessica E. Rothman, Mallery I. Breban, Robert Tobias Koch, Kendall Billig, Joseph R. Fauver, Chantal B.F. Vogels, Sarah Turbett, Kaya Bilguvar, Bony De Kumar, Marie L. Landry, David R. Peaper, Kevin Kelly, Greg Omerza, Heather Grieser, Sim Meak, John Martha, Hannah H. Dewey, Susan Kales, Daniel Berenzy, Kristin Carpenter-Azevedo, Ewa King, Richard C. Huard, Sandra C. Smole, Catherine M. Brown, Timelia Fink, Andrew S. Lang, Glen R. Gallagher, Pardis C. Sabeti, Stacey Gabriel, Bronwyn L. MacInnis, New England Variant Investigation Team, Ryan Tewhey, Mark D. Adams, Daniel J. Park, Jacob E. Lemieux, Nathan D. Grubaugh
medRxiv 2021.10.06.21264641; doi: https://doi.org/10.1101/2021.10.06.21264641

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1105)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9792)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2326)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1566)
  • Health Policy (737)
  • Health Systems and Quality Improvement (607)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11665)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2151)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1184)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2193)
  • Public and Global Health (4680)
  • Radiology and Imaging (784)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (275)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (211)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)